Approximately 44 % ( n = 14 ) of patients in the lithium group , mainly from the cortical stroke subgroup , regained more than 25 % of full function based on hFMA , whereas this rate in the placebo group was 14.7 % ( n = 5 ; P = 0.009 ) .